Starterbites Acquisition Corporation - Cannabis SPAC - V
information
A blank check company being formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Although there is no restriction or limitation on what industry or geographic region our target operates in, we intend to pursue targets in USA, Canada, Europe and Latin America in the Cannabis Industry.
Sponsor
Starterbites Ventures
IPO Dates
2023
Category
Brands, Retail and eComm
SPAC IPO Size
Min 50M US$ ( TBA )
Starterbites Global Acquisition Corporation - Cannabis SPAC - VI
information
A blank check company being formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Although there is no restriction or limitation on what industry or geographic region our target operates in, we intend to pursue targets in USA, Canada, Europe and Latin America in the Cannabis Industry.
CANNABIS SPACs—that’s Cannabis focused special purpose acquisition companies—have been a favorite with fast growing cannabis companies across legalized US and Canadian markets . Over the past three years, licensed cultivation and retail companies have represented more than one-third of all target acquisitions according to market analysis. Q1 2021 saw more cannabis M&A capital than any quarter since Q1 2018. . The vast majority of cannabis deals in the last 12 months have been through SPACs. The current funding boom is a major turnaround for the cannabis industry. SPACs Are Changing the Cannabis Market M&A Landscape
Target acquisitions with top quality product retail alignment, selling the most reputable products in their respective markets at premium prices Leverage scalable cultivation operations Recreational markets are projected to grow
15.3% from 2021 to 2022 Medical markets are projected to grow
14.2% from 2021 to 2022 Interest in illicit markets are projected to
continue to decline as medical markets
and recreational markets grow
OUR PROCESS OF DUE DILIGENCE
1
Project Evaluation
High quality assets and leading positions in high-growth markets
2
Financial Evaluation
Proven ability to deliver profitable inorganic growth at attractive valuations
3
Project Approval
Blue-chip management team with track record of building global brands
FINANCIAL ANALYSIS
GROSS REVENUE
0%
ENTERPRISE VALUATION
0%
EBIDTA
0%
COMPANY ANALYSIS
MANAGEMENT
0%
ROADMAP & PIPELINE
0%
Brands & Retail Strength
0%
WHAT YOU GET OUT OF SPAC M&A ?
Get quick access to growth / expansion capital and become a Public Company and get listed at US / Canadian Exchanges .
PUBLIC COMPANY STATUS
Opportunity to Strong Growth
LISTING AT TOP EXCHANGES
NASDAQ / NYSE / NEO
LARGE INVESTMENT FOR GROWTH
Opportunity to accelerated expansion
TOP GLOBAL ADVISORS
For Leadership and Growth
GLOBAL CUSTOMERS
Opportunity to tap global customers
GO GLOBAL OPPORTUNITY
Tap Global Markets
OUR TEAM
SPAC Leadership
TOP MANAGEMENT TEAM TO SPEARHEAD AND COMPLETE THE M&A